References
- Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. Journal of Thoracic Oncology. 2015;10(9): 1243–1260.
- Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. Journal of Thoracic Oncology. 2011;6(2): 244–285.
- Brady P, McCreary C, O’Halloran KD, Gallagher C. Squamous papilloma causing airway obstruction during conscious sedation. Anesthesia Progress. 2017;64(3): 168–170.
- Fortes HR, von Ranke FM, Escuissato DL, Araujo Neto CA, Zanetti G, Hochhegger B, et al. Recurrent respiratory papillomatosis: a state-of-the-art review. Respiratory Medicine. 2017;126: 116–121.
- Yabuki K, Matsuyama A, Obara K, Takenaka M, Tanaka F, Nakatani Y, et al. A unique case of a huge mixed squamous cell and glandular papilloma of non-endobronchial origin with a peripheral growth. Respiratory Medicine Case Reports. 2018;24: 108–112.
- Mlika M, Anjum F, El Mezni F. Pulmonary papilloma. Treasure Island (FL): StatPearls; 2020.
- Miyoshi R, Menju T, Yoshizawa A. Expression of p16Ink4a in mixed squamous cell and glandular papilloma of the lung. Pathology International. 2017;67(6): 306–310.
- Mitsumoto GL, Bernardi FDC, Paes JF, Villa LL, Mello B, Pozzan G. Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation. Autopsy & Case Reports. 2018;8(3): e2018035.
- Lin D, Jiang Y, Wang J, Ding L, Xin F, Zhao H, et al. Pulmonary mixed squamous cell and glandular papilloma mimicking adenocarcinoma: a case study and literature review. Journal of Thoracic Disease. 2013;5(4): E129–E132.
- Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Annals of Oncology. 2015;26(8): 1604–1620.
- Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of Clinical Oncology. 2008;26(18): 3063–3072.
- Fasano M, Della Corte CM, Papaccio F, Ciardiello F, Morgillo F. Pulmonary large-cell neuroendocrine carcinoma: from epidemiology to therapy. Journal of Thoracic Oncology. 2015;10(8): 1133–1141.
- García-Yuste M, Matilla JM, Alvarez-Gago T, Duque JL, Heras F, Cerezal LJ, et al. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). The Annals of Thoracic Surgery. 2000;70(1): 258–263.
- Akata S, Okada S, Maeda J, Park J, Yoshimura M, Saito K, et al. Computed tomographic findings of large cell neuroendocrine carcinoma of the lung. Clinical Imaging. 2007;31(6): 379–384.
- Chen LC, Travis WD, Krug LM. Pulmonary neuroendocrine tumors: what (little) do we know? Journal of the National Comprehensive Cancer Network. 2006;4(6): 623–630.
- Chaves E, Pessoa Toão, Campobasso O, Chrétien J, Hochholzer L, Kreyberg L, et al. Histological Typing of Lung Tumours. Tumori. 1981;67(4): 253–272.